TheraRadar
Clinical-Stage Companies / Daewoong Pharmaceutical

Daewoong Pharmaceutical

Pre-Approval PRO BETA
116
Total Trials
36
Phase 3
8
Phase 2
6
Recruiting
843
Score

Pipeline by Phase

Phase 3
36
Phase 2
8
Phase 1
63

Therapeutic Focus

Healthy Healthy Volunteers T2DM (Type 2 Diabetes Mellitus) Hypertension Idiopathic Pulmonary Fibrosis

Clinical Trials (116)

NCT06682000 Phase 3 COMPLETED

Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension

Started: 1/20/2025

NCT05643508 Phase 3 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

Started: 2/23/2023

NCT06671392 Phase 3 COMPLETED

A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension

Started: 2/24/2025

NCT06751121 Phase 3 COMPLETED

Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori

Started: 2/6/2024

NCT07013279 Phase 3 NOT YET RECRUITING

Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines

Started: 7/15/2025

NCT06062030 Phase 3 COMPLETED

Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;

Started: 3/8/2024

NCT06606093 Phase 3 NOT YET RECRUITING

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients

Started: 9/23/2024

NCT04784910 Phase 3 COMPLETED

Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer

Started: 5/21/2021

NCT06354127 Phase 3 COMPLETED

DWP450 for Treating Moderate to Severe Glabellar Lines

Started: 8/12/2020

NCT03946592 Phase 3 COMPLETED

Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

Started: 5/15/2019

NCT04713176 Phase 3 TERMINATED

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

Started: 2/2/2021

NCT02947620 Phase 3 COMPLETED

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

Started: 8/1/2015

NCT05813561 Phase 3 COMPLETED

The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis

Started: 12/30/2021

NCT04721535 Phase 3 TERMINATED

A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

Started: 6/7/2021

NCT04294251 Phase 3 COMPLETED

Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy

Started: 3/4/2020

NCT05376969 Phase 3 COMPLETED

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin

Started: 5/25/2021

NCT05376930 Phase 3 COMPLETED

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

Started: 9/16/2021

NCT04632862 Phase 3 COMPLETED

The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

Started: 11/11/2020

NCT04634500 Phase 3 COMPLETED

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.

Started: 11/18/2020

NCT04654390 Phase 3 COMPLETED

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

Started: 12/30/2020

NCT03009487 Phase 3 COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Started: 1/1/2017

NCT04341454 Phase 3 COMPLETED

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Started: 6/2/2020

NCT03736369 Phase 3 COMPLETED

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

Started: 12/13/2018

NCT03024086 Phase 3 COMPLETED

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia

Started: 12/12/2016

NCT03184415 Phase 3 TERMINATED

Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis

Started: 7/3/2017

NCT03184402 Phase 3 COMPLETED

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

Started: 4/24/2017

NCT02490111 Phase 3 COMPLETED

Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer

Started: 5/1/2015

NCT01945684 Phase 3 COMPLETED

A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity

Started: 9/1/2013

NCT01629199 Phase 3 COMPLETED

Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus

Started: 10/1/2010

NCT01764295 Phase 3 COMPLETED

Clinical Study for Patients With Hypertension Associated With Dyslipidemia

Started: 9/1/2012

NCT01636401 Phase 3 COMPLETED

Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Started: 8/1/2012

NCT01629875 Phase 3 COMPLETED

Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

Started: 3/1/2012

NCT01634308 Phase 3 COMPLETED

Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation

Started: 6/1/2010

NCT07619833 Phase 3 NOT YET RECRUITING

To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus

Started: 6/1/2026

NCT05389215 Phase 2 RECRUITING

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

Started: 7/29/2022

NCT05378360 Phase 2 COMPLETED

DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities

Started: 5/2/2022

NCT03224117 Phase 2 COMPLETED

Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

Started: 10/26/2017

NCT05226533 Phase 2 TERMINATED

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

Started: 3/31/2022

NCT04521296 Phase 2 TERMINATED

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Started: 9/11/2020

NCT03184324 Phase 2 COMPLETED

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

Started: 8/28/2017

NCT02947815 Phase 2 COMPLETED

Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm

Started: 10/1/2016

NCT01557010 Phase 2 COMPLETED

Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia

Started: 3/1/2012

NCT07371104 Phase 1 RECRUITING

Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer

Started: 4/22/2026

NCT07260851 Phase 1 RECRUITING

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions

Started: 11/5/2025

NCT07267221 Phase 1 RECRUITING

Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.

Started: 12/1/2025

NCT07144176 Phase 1 RECRUITING

PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers

Started: 9/1/2025

NCT06736587 Phase 1 RECRUITING

Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers

Started: 12/10/2024

NCT07539415 Phase 1 NOT YET RECRUITING

A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

Started: 3/30/2026

NCT07213310 Phase 1 COMPLETED

Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults

Started: 11/9/2025

NCT07256600 Phase 1 COMPLETED

PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers

Started: 11/14/2025

NCT05607589 Phase 1 WITHDRAWN

The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects

Started: 10/1/2022

NCT06644404 Phase 1 NOT YET RECRUITING

Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults

Started: 10/26/2024

NCT06592495 Phase 1 NOT YET RECRUITING

Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

Started: 10/1/2024

NCT06508645 Phase 1 COMPLETED

Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers

Started: 1/10/2022

NCT06437951 Phase 1 NOT YET RECRUITING

to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection

Started: 7/1/2024

NCT04159961 Phase 1 COMPLETED

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

Started: 12/24/2019

NCT06212960 Phase 1 COMPLETED

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Started: 11/28/2023

NCT05832697 Phase 1 COMPLETED

An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

Started: 1/27/2022

NCT05816681 Phase 1 COMPLETED

Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

Started: 8/22/2022

NCT05304845 Phase 1 COMPLETED

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

Started: 3/21/2022

NCT05574374 Phase 1 COMPLETED

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

Started: 9/21/2022

NCT05465668 Phase 1 COMPLETED

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

Started: 7/22/2022

NCT04782505 Phase 1 COMPLETED

Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

Started: 3/12/2021

NCT05414591 Phase 1 COMPLETED

Pharmacokinetics and Safety Following Administration of DWP16001

Started: 5/1/2021

NCT05192395 Phase 1 COMPLETED

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

Started: 4/15/2022

NCT04749173 Phase 1 COMPLETED

To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.

Started: 11/21/2020

NCT05149274 Phase 1 COMPLETED

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Started: 10/1/2021

NCT04888715 Phase 1 COMPLETED

To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

Started: 7/23/2021

NCT04541485 Phase 1 TERMINATED

To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)

Started: 12/4/2020

NCT04328766 Phase 1 COMPLETED

Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

Started: 9/6/2020

NCT04767815 Phase 1 COMPLETED

To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers

Started: 3/22/2021

NCT04888728 Phase 1 COMPLETED

To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers

Started: 6/30/2021

NCT04393597 Phase 1 WITHDRAWN

Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults

Started: 5/28/2020

NCT04278391 Phase 1 COMPLETED

Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers

Started: 7/2/2019

NCT04064073 Phase 1 COMPLETED

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)

Started: 8/14/2019

NCT03364985 Phase 1 COMPLETED

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers

Started: 12/3/2017

NCT03574415 Phase 1 COMPLETED

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean

Started: 11/1/2018

NCT03487562 Phase 1 COMPLETED

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

Started: 4/8/2018

NCT03947489 Phase 1 COMPLETED

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Started: 3/4/2019

NCT03573622 Phase 1 COMPLETED

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Started: 5/31/2018

NCT03574285 Phase 1 COMPLETED

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions

Started: 5/31/2018

NCT03753477 Phase 1 COMPLETED

Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

Started: 12/22/2017

NCT03512808 Phase 1 COMPLETED

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

Started: 6/1/2017

NCT03512821 Phase 1 COMPLETED

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

Started: 10/1/2017

NCT02757144 Phase 1 COMPLETED

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

Started: 3/1/2016

NCT02952755 Phase 1 COMPLETED

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers

Started: 11/28/2016

NCT02952547 Phase 1 COMPLETED

Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

Started: 10/30/2016

NCT02704559 Phase 1 COMPLETED

Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects

Started: 12/1/2015

NCT02947139 Phase 1 COMPLETED

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers

Started: 9/29/2016

NCT02622685 Phase 1 COMPLETED

A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

Started: 5/1/2015

NCT02369302 Phase 1 COMPLETED

Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers

Started: 1/1/2015

NCT02502721 Phase 1 COMPLETED

A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

Started: 6/1/2015

NCT02385032 Phase 1 COMPLETED

Comparative Bioavailability Study of UDCA

Started: 2/1/2015

NCT02089399 Phase 1 COMPLETED

Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

Started: 5/1/2014

NCT02332044 Phase 1 COMPLETED

Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

Started: 4/1/2014

NCT01423526 Phase 1 COMPLETED

A Single Dose Study of DWP10292 in Healthy Male Subjects

Started: 8/1/2011

NCT01964365 Phase 1 COMPLETED

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers

Started: 9/1/2013

NCT01522586 Phase 1 TERMINATED

Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031

Started: 1/1/2012

NCT01653314 Phase 1 COMPLETED

Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers

Started: 1/1/2012

NCT01651858 Phase 1 COMPLETED

Nurigra Chewable Tablet in Healthy Adult Male Volunteers

Started: 2/1/2012

NCT01415466 Phase 1 COMPLETED

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

Started: 8/1/2011

NCT01493856 Phase 1 COMPLETED

A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

Started: 1/1/2012

NCT01094847 Phase 1 COMPLETED

Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine

Started: 4/1/2010

NCT01094834 Phase 1 COMPLETED

A Multiple Dose Study of DWP05195 in Healthy Adult Subjects

Started: 4/1/2010

NCT00969787 Phase 1 COMPLETED

DWP05195 in Healthy Adult Male Volunteers

Started: 4/1/2009

NCT07533266 Phase 4 NOT YET RECRUITING

Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer

Started: 4/1/2026

NCT06000657 Phase 4 COMPLETED

Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir

Started: 8/28/2023

NCT06272630 Phase 4 COMPLETED

Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease

Started: 2/6/2023

NCT05072938 Phase 4 COMPLETED

Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis

Started: 9/30/2021

NCT04120753 Phase 4 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

Started: 8/26/2019

NCT05410535 Phase 4 COMPLETED

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Started: 9/15/2021

NCT03485534 Phase 4 COMPLETED

Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients

Started: 1/23/2018

NCT02415777 Phase 4 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction

Started: 10/1/2014

NCT02568150 Phase 4 COMPLETED

Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines

Started: 2/1/2014

NCT02418130 Phase 4 COMPLETED

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.

Started: 10/1/2014

NCT01634321 Phase 4 COMPLETED

The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

Started: 7/1/2011

Drug Candidates

DWC202404, DWC202314 DWC202404, DWC202314P DWZ2501 (Olaparib 150mg) DWC202510 (Olaparib 150mg) (D) DWC202206 (D) DWC202207 (P) DWC202206 (P) DWC202207 DWRX5003 DWC202502
Activity Status: Active
Last Trial Started: 6/1/2026
Last Trial Ended: 2/5/2026
Trials (12 months): 10
Completed Trials: 93
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.